30
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Public Timelines
FAQ
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Open cabinet
For educational institutions
For teachers
For students
Open cabinet
Crear
Close
Create a timeline
Public timelines
Library
FAQ
Descargar
Export
Crear una copia
Premium
Insertar en el Sitio Web
SCLC treatment evolution
Actualizado 4 mar 2020
0
0
183
Share
Autores
Created by
Halocy
List of Edits
Attachments
Comments
Eventos
1942: nitrogen mustard first used [3]
1968: SCLC divided into limited disease (LD) and extensive disease (ED) stages [3]
1969: Cyclophosphamide single-agent chemotherapy shown to be effective [3]
1969: Medical Research Council: superior survival benefit with primary radical radiation therapy compared to surgery [3]
March 2019: Atezolizumab approved as first line treatment for ES-SCLC by FDA
Períodos
1959-1962 Recognition of small cell lung cancer (SCLC) as a separate category from other lung cancers [3]
1970s: Combination therapy shows dramatic responses. Fraction of patients experienced very long-term disease-free survival [3]
1980s: Combination cisplatin/etoposide with chemotherapy becomes treatment of choice [3]
1990s: Chemotherapy used for relapsed disease [4]
2000s: Development and study of new therapeutic targets for SCLC with mixed results [3]
About & Feedback
Acuerdo
Privacidad
Biblioteca
2024
©
Time.Graphics
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on
Trustpilot.com
Comments